Drug profile · INN
PTU
propylthiouracil (PTU) is a thyroid peroxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
propylthiouracil (PTU) is a thyroid peroxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Thyroid peroxidase inhibitor
Primary target: Thyroid peroxidase
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
🔒 FDA CBER Patient Listening Meeting on Gene Therapy Safety: Patient and Care Partner Perspectives
FDA CBER held a dedicated patient listening meeting focused on two core themes: safety considerations in gene therapy treatment decisions an…
🔒 Institutional Recognition of SoTL in Health Professions Education: Scoping Review for Education
SoTL is described with shared core concepts across health professions education literature, but operationalized in varied ways that often bl…
propylthiouracil (PTU) is a thyroid peroxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
PTU is a marketed brand name for propylthiouracil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
propylthiouracil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.